GGrantIndex
← Leaderboards

Derrick E Fouts

Institute For Genomic Research

$13,590,043
Attributed
$18,708,674
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,860,626 · 5
CDC$5,848,048 · 1

By mechanism

U54$12,267,586 · 2
R01$2,908,260 · 1
U01$1,677,878 · 1
U19$1,432,187 · 1
R21$422,763 · 1

Top collaborators

Most similar at Institute For Genomic Research

Same institution · by research overlap

Others in their field

Top investigators on “Acute

Research focus

AcuteBacteriaBlood CirculationMortalityGenomicsLaboratoriesMolecularEtiologyMorbidity - Disease RatePathogenBacteriophagesMicrobiomeInfectionDesignEnterobacteriaceaeFutureVirusInnovationPathogenic BacteriaResistant Klebsiella PneumoniaeCarbapenem ResistanceBaseAffectInsight

Grant awards (25)

Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$1,234,778
U54 · FY2025 · TW
Optimization, Manufacturing and Testing of a Lead Therapeutic Bacteriophage Cocktail for the Treatment of Antibiotic-Resistant Klebsiella pneumoniae Infections$1,068,054
R01 · FY2025 · AI · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$589,572
U54 · FY2025 · CK · contact PI
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$332,303
U54 · FY2025 · TW
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$1,264,691
U54 · FY2024 · TW
Optimization, Manufacturing and Testing of a Lead Therapeutic Bacteriophage Cocktail for the Treatment of Antibiotic-Resistant Klebsiella pneumoniae Infections$918,873
R01 · FY2024 · AI · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$594,596
U54 · FY2024 · CK · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$244,444
U54 · FY2024 · CK · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$1,461,621
U54 · FY2023 · CK · contact PI
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$1,243,005
U54 · FY2023 · TW
Optimization, Manufacturing and Testing of a Lead Therapeutic Bacteriophage Cocktail for the Treatment of Antibiotic-Resistant Klebsiella pneumoniae Infections$921,333
R01 · FY2023 · AI · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$1,448,172
U54 · FY2022 · CK · contact PI
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$1,198,845
U54 · FY2022 · TW
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2022 · AA
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)$1,145,916
U54 · FY2021 · TW
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2021 · AA
Human Milk Oligosaccharides for Prevention of Alcohol-Associated Liver Disease$157,750
U01 · FY2021 · AA
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$967,238
U54 · FY2020 · CK · contact PI
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter$542,405
U54 · FY2020 · CK · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2020 · AA
Microbiome as therapeutic target in alcoholic hepatitis$305,515
U01 · FY2019 · AA
Microbiome as therapeutic target in alcoholic hepatitis$309,999
U01 · FY2018 · AA
Genomics of Antibiotic Resistance in Bacterial Pathogens$1,432,187
U19 · FY2016 · AI · contact PI
Metgagenomic Analysis of the Human Oral Viral Microbiome$232,160
R21 · FY2008 · DE · contact PI
Metgagenomic Analysis of the Human Oral Viral Microbiome$190,603
R21 · FY2007 · DE · contact PI